0001213900-17-006380.txt : 20170612 0001213900-17-006380.hdr.sgml : 20170612 20170612172056 ACCESSION NUMBER: 0001213900-17-006380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170608 FILED AS OF DATE: 20170612 DATE AS OF CHANGE: 20170612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUBIN ROBERT J. CENTRAL INDEX KEY: 0001413631 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 17907356 MAIL ADDRESS: STREET 1: 7901 SPRINGER ROAD CITY: BETHESDA STATE: MD ZIP: 20817 FORMER NAME: FORMER CONFORMED NAME: Rubin Robert Joseph DATE OF NAME CHANGE: 20070926 4 1 f4060817rubin_soligenix.xml OWNERSHIP DOCUMENT X0306 4 2017-06-08 0 0000812796 SOLIGENIX, INC. SNGX 0001413631 RUBIN ROBERT J. 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540 1 0 0 0 Stock Option (Right to Buy) 2.29 2017-06-08 4 A 0 13100 0 A 2027-06-07 Common Stock 13100 13100 D The stock option vests ratably on each of September 8, 2017, December 8, 2017, March 8, 2018 and June 8, 2018. /s/ Robert J. Rubin 2017-06-09